Final answer:
Protein misfolding in neurodegenerative diseases like HD can be targeted for treatment by interfering with the accumulation of misfolded proteins.
Step-by-step explanation:
Protein misfolding in neurodegenerative diseases like Huntington's Disease (HD) can be targeted for treatment by interfering with the accumulation of misfolded proteins.
The accumulation of these proteins can lead to the formation of toxic aggregates and plaques, which contribute to disease progression. By developing drugs or therapies that prevent or reduce protein misfolding and aggregation, it may be possible to alleviate the symptoms and slow the progression of HD.